|
Volumn 5, Issue 4, 2009, Pages 253-256
|
Management of C. difficile infection in IBD
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
METRONIDAZOLE;
PROBIOTIC AGENT;
STEROID;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
VANCOMYCIN;
ADD ON THERAPY;
ANTIBIOTIC THERAPY;
ANTIBODY RESPONSE;
CLINICAL TRIAL;
CLOSTRIDIUM DIFFICILE INFECTION;
COLITIS;
COLON RESECTION;
DETERIORATION;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG DOSE ESCALATION;
DRUG MEGADOSE;
DRUG TOLERABILITY;
DRUG TREATMENT FAILURE;
ENTERITIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FECES ANALYSIS;
HOSPITALIZATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFECTION RISK;
LACTOBACILLUS;
LENGTH OF STAY;
MAINTENANCE THERAPY;
MORTALITY;
NOTE;
OUTPATIENT CARE;
PROCTOCOLECTOMY;
RELAPSE;
SACCHAROMYCES BOULARDII;
|
EID: 66949181205
PISSN: 15547914
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (1)
|
References (6)
|